ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 333

Deletion of the Prolactin Receptor Aggravates the Course of Antigen-Induced Arthritis

Norma Adan, Maria G. Ledesma-Colunga, Ana L. Reyes-Lopez, Fernando Lopez-Barrera, Gonzalo Martinez de la Escalera and Carmen Clapp, Institute of Neurobiology, National University of Mexico (UNAM), Queretaro, Mexico

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: hormones, inflammatory arthritis, pain and prolactin

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Prolactin (PRL), the hormone essential for lactation, may protect against joint damage in rheumatoid arthritis. PRL frequently increases in the circulation of patients with rheumatoid arthritis, and eliciting hyperprolactinemia in rats before or after inducing the adjuvant model of inflammatory arthritis reduced chondrocyte apoptosis, proinflammatory cytokine expression, pannus formation, joint swelling, and pain (Adan et al., J Clin Invest 123:3902, 2013). 

Methods: To better understand the role of PRL in inflammatory arthritides, antigen-induced arthritis (AIA) was induced in PRL receptor-deficient (Prlr-/-) mice from two susceptible genetic backgrounds (C57BL/6 and 129Svj). On day 0, preimmunized or control animals were injected into the knee joint with methylated-BSA antigen (mBSA) or vehicle, respectively, and parameters of inflammation were evaluated at days -1, +1, +3, and +5 post-mBSA. 

Results: In the 129Svj strain, Prlr-/- mice showed an earlier onset of AIA but similar clinical severity (joint swelling and pain) compared to wild type mice. However, PRLR-deficient mice had a two-fold increase in synovial hyperplasia and higher levels of circulating IL-6. In the C57BL/6 strain, Prlr-/- mice displayed similar joint swelling but increased mechanical allodynia compared to Prlr-+/+ mice.  Consistent with augmented pain, a two-fold enhanced synovial hyperplasia occurred in the absence of the PRLR, although circulating levels of IL-6 were similar between Prlr-/- and Prlr-+/+ mice.

Conclusion: Loss of the PRLR correlates with an aggravated AIA phenotype with different symptoms depending on the genetic background. These findings support the protective role of the PRL system in inflammatory arthritis. Work supported by UNAM-Grant IN200312.


Disclosure:

N. Adan,
None;

M. G. Ledesma-Colunga,
None;

A. L. Reyes-Lopez,
None;

F. Lopez-Barrera,
None;

G. Martinez de la Escalera,
None;

C. Clapp,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deletion-of-the-prolactin-receptor-aggravates-the-course-of-antigen-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology